 FDA Expert Panel on Infant Formula Invitation
June 4, 2025, 10 a.m. - noon ET
As part of the Trump Administration’s commitment to transform American health care and rebuild trust in public health, the FDA Commissioner Marty Makary, M.D., M.P.H., will lead a roundtable discussion of an independent panel of scientific experts to discuss the latest science on infant nutrition.
You are invited to attend this public roundtable on Wednesday, June 4, 2025, at 10 a.m. ET. This roundtable will follow a transparent process grounded in gold standard science, setting precedents for future discussions.
The expert panel discussion will take place at the FDA’s White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, in the Great Room. The public and members of the media may attend the event. The session will be livestreamed.
Journalists and media representatives attend FDA Expert Panel events. They may photograph or record audio/video of sessions and presentation slides for accurate reporting. The FDA also livestreams these panels on its social media channels.
Please plan to arrive by at least 9:30 a.m. (30 min early) to allow for enough time to park your vehicle, get on the campus shuttle, and get through security screening. If you are planning to use a taxi, rideshare or car service, you will not have to take the campus shuttle and can be dropped off directly in front of Building 1. Below is a link to the campus map to this invitation. Please find information about visitor parking here: Visitor Parking and Campus Map | FDA
Space is limited. Registration is only required for in-person attendance. Please use the link below to register and plan to arrive at least 30 minutes prior to the start time to be checked in.
Please use the link below to view via livestream
About Us
The Public Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, patients and patient advocacy organizations, consumer groups, trade associations, think tanks and academia, and other interested parties, in order to better inform our policy making process, identify policy hurdles or misconceptions, and create strategic collaborations. For more information, please contact us at ForPatients@fda.hhs.gov. For patient specific inquiries, please contact us at Patients Ask FDA.
|
